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Abstract 
Background: Enteropathy-associated T-cell lymphoma (EATL) is a rare and aggressive 
type of extranodal T-cell lymphoma (TCL) arising in the gastrointestinal (GI) tract and 
represents 5–8% of all T-cell non-Hodgkin lymphomas (NHL) and 10–25% of primary 
intestinal lymphomas. 
Case presentation: We reported a 78-year-old woman presenting with severe 
hypocalcemia. Investigations confirmed vitamin D and iron deficiency as well as 
hypoalbuminemia. Celiac disease was suspected and confirmed, but despite intravenous 
calcium and magnesium supplementation and a gluten-free diet, normal electrolyte levels 
were never reached. Intestinal perforation was the clue to the diagnosis of enteropathy-
associated T-cell lymphoma (EATL).  
Conclusion: Hypocalcemia can result from multiple conditions. In patients not responding 
to adequate supplementation, further investigations should be performed to diagnose the 
underlying condition 
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Hypocalcemia is an electrolyte disorder commonly encountered on medical and 
surgical services. While low serum calcium concentrations are often caused by disorders of 
parathormone (PTH) or vitamin D, this condition may result from a wide spectrum of 
clinical conditions. Therefore, full investigations are required to identify the underlying 
cause, particularly in patients not responding to adequate supplementation. Hypocalcemia 
can also be seen in malignant diseases (1, 2). A large variety of different and intriguing 
mechanisms leading to hypocalcemia may be involved but their full spectrum is not widely 
recognized. It has been suggested that this metabolic disorder occurs via mechanisms 
pertaining to osteoblastic-stimulating factors or toxic effects of certain chemotherapeutic 
agents (3).  We reported a 78-year-old woman presenting with severe hypocalcemia in the 
setting of enteropathy-associated T-cell lymphoma.  
 
 
Case Presentation 
A 78-year-old woman presented to the emergency department complaining of 
paresthesias in her upper limbs and inability to open her hands over the last four hours. 
The patient experienced weight loss of about 14 kg over the previous 2 months, loss of 
appetite, and two to three liquid stools per day over the last 3 days. 
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Her medical history revealed a long history of 
hypertension, osteoporosis. Family history was 
noncontributory. Her current medications included 
bisoprolol 2.5 mg daily, calcium/vitamin D3 
supplementation, and denosumab 60 mg every 6 months. 
Initial evaluation in the emergency department revealed 
marked hypocalcemia with a total calcium 6.0 mg/dL 
(normal 8.2 to 10.50 mg/dL) and ionic calcium 0.97 mmol/L 
(normal 1.15 to 1.35 mmol/L), hypomagnesemia (0.56 
mg/dL), and normal phosphorus, renal function, white blood 
count, and hemoglobin. The chest x-ray and the 
electrocardiogram were normal. She was transferred to the 
Department of Internal Medicine. On physical exam, the 
patient looked ill. Blood pressure, heart rate, and oxygen 
saturation were normal.  
The cardiorespiratory system examination was normal, as 
well as the abdominal exam. Neurological exam was normal 
but she complained of paresthesias. The patient’s laboratory 
testing revealed no other electrolyte disorders, normal liver 
function, and normal blood gases. Her folic acid, vitamin D, 
and serum iron levels were low: 2.7 ug/L (normal: 5 to 15 
µg/l), 14 ng/mL (normal: 30 to 50 ng/mL) and 18 ug/mL 
(normal: 25 to 150 ng/mL), respectively. A normochromic 
normocytic anemia was found. Albumin and total proteins 
were also low. Parathormone (PTH) was 452 pg/mL 
(normal: 0.00 to 68.2 pg/mL). Her thyroid function, lipid 
panel, and vitamin B12 levels were normal, and 
sedimentation rate was within the normal range. 
Autoimmune panel revealed positivity for anti-gliadin IgG 
antibodies and negativity for anti-transglutaminase and anti-
endomysium antibodies. Anti-Saccharomyces cerevisiae 
antibodies (ASCA) antibodies were negative. The genetic 
studies revealed positivity for DR3DQ2 and DR4DQ8 
haplotypes. Fecal chymotrypsin, calprotectin, and antitrypsin 
had increased.  
The patient underwent an upper endoscopy revealing the 
presence of villous atrophy in the proximal and middle small 
intestine without ulcers, findings that were consistent with 
celiac disease. The first abdominal computed tomography 
(CT) was read as negative. The patient was started on a 
gluten-free diet and intravenous calcium and magnesium 
supplementation with good clinical response. One week after 
admission the patient developed upper right quadrant pain 
and fever consistent with acute cholecystitis, confirmed by 
ultrasound, and she was started on intravenous antibiotics. 
Five days later, she developed edema in the left lower limb 
and a positive D-dimer. Venous doppler ultrasound and 
computed tomography of the chest confirmed the presence of 
deep venous thrombosis and pulmonary thromboembolism. 
Anticoagulation with low molecular weight heparin was 
initiated. There was no evidence of right ventricular 
dysfunction on the echocardiogram.  
On day 27 of admission the patient complained of acute 
abdominal pain. The abdominal computed tomography was 
consistent with intestinal perforation of uncertain location. 
The computed tomography also revealed the presence of 
abdominal adenopathy. She underwent resection of the distal 
jejunum and ileum. The anatomical and pathological study 
of the intestinal tissue showed transmural and multifocal 
infiltration (three lesions of about 3.2 cm in maximum 
diameter) with intestinal T-cell lymphoma with 
histopathological features compatible with T-cell lymphoma-
associated with enteropathy.  
There were also signs of fibrinopurulent peritonitis. After 
surgery, the patient was transferred to the intensive care unit 
for the management of septic shock. She received 13 days of 
intravenous antibiotics with good clinical response. She was 
readmitted to the internal medicine department. The 
immunophenotype showed positivity for CD3, CD7, and 
CD30, partial positivity for CD2, CD4, and TIA1, and 
negativity for CD20, CD5, CD8, and CD56. Ki-67 was 
elevated consistently with a high proliferative index. 
Intravenous calcium and magnesium supplementation were 
eventually switched to oral supplementation and oral feeding 
was started. The patient refused oral anticoagulation and 
treatment for the lymphoma. She was discharged from the 
hospital 3 months after admission.  
 
 
Discussion 
Parathyroid hormone (PTH), vitamin D, calcium ion 
itself, and phosphate are the primary physiologic factors 
influencing serum calcium concentration (1). Parathyroid 
hormone and vitamin D disturbances are the most common 
causes of hypocalcemia. The metabolic panel of our patient 
showed hypocalcemia, low vitamin D and magnesium levels, 
and high PTH levels. It is likely that her PTH increased to 
compensate for a low serum calcium concentration, 
increasing reabsorption of calcium from the kidneys and 
bones and increasing production of 1,25-dihydroxyvitamin 
D. In addition, hypomagnesemia may increase PTH levels by 
parathyroid hormone (PTH) resistance (1, 2). 
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Another factor that may have contributed to 
hypocalcemia in this patient was treatment with denosumab. 
This is a human monoclonal antibody to the receptor 
activator of nuclear factor κB ligand (RANKL), leading to 
inhibition of osteoclast formation, decreasing bone 
resorption, and increasing bone mineral density (BMD) (3, 4, 
5). In patients receiving this drug, underlying medical 
conditions such as vitamin D deficiency and malabsorption 
syndromes may predispose to the development of 
hypocalcemia as seen in our patient. Some reports have 
suggested hypocalcemia may arise after the first dose of 
denosumab with a median time from drug administration to 
calcium nadir of 25 days (ranging from 14 to 106 days) and 
median time to recover baseline calcium of 17 days (ranging 
from 6 to 40 days) (6). In the current case, our patient had 
received two doses with the last one being 3 months prior to 
hospitalization. Further testing was performed to determine 
why calcium levels remained low despite supplementation. 
Laboratory results showed decreased albumin and iron 
deficiency, suggesting malabsorption which was confirmed 
through the exams performed. Nevertheless, despite a 
gluten-free diet, IV calcium, and magnesium 
supplementation as well as vitamin D supplementation, 
optimal levels were never reached. 
The intestinal perforation was the key factor in the 
discovery of the underlying disease of T-celllymphoma. 
Enteropathy-associated T-cell lymphoma (EATL) is a rare 
and aggressive type of extranodal T-cell lymphoma (TCL) 
arising in the gastrointestinal (GI) tract and represents 5–8% 
of all T-cell non-Hodgkin lymphomas (NHL) and 10–25% of 
primary intestinal lymphomas (7, 8). It is most commonly 
seen in men (in contrast to our patient) between the sixth and 
seventh decades of life. Type I EATL has been strongly 
associated with HLA-DQ2/DQ8 genotype and celiac disease 
(9). Gastrointestinal symptoms such as diarrhea, abdominal 
pain, and B symptoms are often the initial presentation.  In 
contrast to the case, hypercalcemia is most commonly seen, 
reaching up to 91% in one of the series published (7).  In the 
case presented, diarrhea developed early prior to admission 
and there was no previous history of celiac disease, but she 
did have a history of weight loss. Intestinal obstruction and 
perforation, as seen in this case, occur frequently in these 
patients. Studies are unclear about a beneficial effect of 
adherence to a gluten-free diet on EATL risk reduction (7). It 
is likely that T-cell lymphoma was already established in our 
patient by the time she developed her symptoms. Like most 
T-cell lymphoma subtypes, there is no standard of care for 
newly diagnosed EATL. However, CHOP-based 
chemotherapy with or without consolidative autologous stem 
cell transplantation (ASCT) remains the mainstay of 
treatment (10). 
In conclusions hypocalcemia can result from multiple 
conditions. In patients not responding to adequate 
supplementation, further investigations should be performed 
to diagnose the underlying condition  
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